Clinical Trial Update: A Clinical Study of MT1002 in Subjects With Acute Coronary Syndrome Undergoing PCI [Phase 2]

View source ↗

Summary

This document announces a Phase 2 clinical trial evaluating MT1002 in subjects with Acute Coronary Syndrome undergoing PCI, sponsored by Shaanxi Micot Pharmaceu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• MT1002

Snippet

Sponsor: Shaanxi Micot Pharmaceutical Technology Co., Ltd. | Conditions: Acute Coronary Syndrome | Phase 2 | Status: RECRUITING